Jianfeng Shen

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Oncogenesis

Nature medicine

Nature communications

Scientific data

Shanghai Jiao Tong University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Jiao Tong University School of Medicine

China

Principle Investigator :: Ninth People's Hospital

University of Pennsylvania Jul 26 2010 - Nov 05 2012

United States

Postdoc Fellow :: School of Medicine

Publications

Zhe Zhang, Chen Li, Qian Li, Xiaoming Su, Jiayi Li, Lili Zhu, Xinhua James Lin, Jianfeng Shen
Structure prediction of novel isoforms from uveal melanoma by AlphaFold. Scientific data 10 (1) (2023)
Chunyan Zong, Zhe Zhang, Li Gao, Jie He, Yiran Wang, Qian Li, Xiaoting Liu, Jie Yang, Di Chen, Rui Huang, Guopei Zheng, Xiaoliang Jin, Wu Wei, Renbing Jia, Jianfeng Shen
APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors. Cell death & disease 14 (6) (2023)
Teng-Teng Yao, Zhe Zhang, Qian Li, Rui Huang, Yanhong Hong, Chen Li, Feng Zhang, Yingying Huang, Yan Fang, Qin Cao, Xiao-Liang Jin, Chunliang Li, Zefeng Wang, Xinhua James Lin, Lingjie Li, Wu Wei, Zhao-Yang Wang, Jianfeng Shen
Long-read sequencing reveals alternative splicing-driven, shared immunogenic neoepitopes regardless SF3B1 status in uveal melanoma. Cancer immunology research (2023)
Jiahao Shi, Xiaoliang Jin, Yihao Wang, Tianyu Zhu, Dongmei Zhang, Qian Li, Xiaomin Zhong, Yaqi Deng, Jianfeng Shen, Xianqun Fan
LIN28B inhibition sensitizes cells to p53-restoring PPI therapy through unleashed translational suppression. Oncogenesis 11 (1) (2022)
Chunyan Zong, Tianyu Zhu, Jie He, Rui Huang, Renbing Jia, Jianfeng Shen
PARP mediated DNA damage response, genomic stability and immune responses. International journal of cancer 150 (11) (2022)
Min Zhou, Jianlong Yuan, Yaqi Deng, Xianqun Fan, Jianfeng Shen
Emerging role of SWI/SNF complex deficiency as a target of immune checkpoint blockade in human cancers. Oncogenesis 10 (1) (2021)
Yihao Wang, Rui Huang, Guopei Zheng, Jianfeng Shen
Small ring has big potential: insights into extrachromosomal DNA in cancer. Cancer cell international 21 (1) (2021)
Hui-Ju Hsieh, Wei Zhang, Shu-Hong Lin, Wen-Hao Yang, Jun-Zhong Wang, Jianfeng Shen, Yiran Zhang, Yiling Lu, Hua Wang, Jane Yu, Gordon B Mills, Guang Peng
Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery. Nature communications 9 (1) (2018)
Jianfeng Shen, Zhenlin Ju, Wei Zhao, Lulu Wang, Yang Peng, Zhongqi Ge, Zachary D Nagel, Jun Zou, Chen Wang, Prabodh Kapoor, Xiangyi Ma, Ding Ma, Jiyong Liang, Shumei Song, Jinsong Liu, Leona D Samson, Jaffer A Ajani, Guo-Min Li, Han Liang, Xuetong Shen, Gordon B Mills, Guang Peng
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade. Nature medicine 24 (5) (2018)
Xiaojuan Lin, Jianfeng Shen, null Dan Peng, Xinhong He, Congjian Xu, Xiaojun Chen, Janos L Tanyi, Kathleen Montone, Yi Fan, Qihong Huang, Lin Zhang, Xiaomin Zhong
RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2/FOXO3A/BIM axis in ovarian cancer cells. Signal transduction and targeted therapy 3 (2018)

Jianfeng Shen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jianfeng Shen